IPHA
Innate Pharma
IPHA
IPHA
10 hedge funds and large institutions have $282K invested in Innate Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$27.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$22.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.77K |
| 4 |
GI
GAMMA Investing
Foster City,
California
|
+$3.98K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5 |
Top Sellers
| 1 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$26K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$828 |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
-$368 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ETC
1
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $112K | -$26K | -14,598 | -19% |
|
2
Morgan Stanley
New York
| $77.5K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $43.2K | +$22.1K | +12,414 | +105% |
|
|
4
Millennium Management
New York
| $27.3K | +$27.3K | +15,326 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $16K | +$9.77K | +5,491 | +156% |
|
|
GI
6
GAMMA Investing
Foster City,
California
| $3.98K | +$3.98K | +2,233 | New |
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $1.2K | – | – | – |
|
8
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
9
Optiver Holding
Amsterdam,
Netherlands
| $180 | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $5 | +$5 | +3 | New |
|
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$828 | -450 | Closed |
|
|
SPIA
12
Steward Partners Investment Advisory
New York
| – | -$368 | -200 | Closed |
|